Patents by Inventor George Mullen

George Mullen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11981417
    Abstract: A heated floor panel may comprise a base assembly and a heating element located on a first surface of the base assembly. A panel skin may be located over the heating element and the first surface of the base assembly. The panel skin may extend from the first surface of the base assembly to a second surface of the base assembly opposite the first surface of the base assembly.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 14, 2024
    Assignee: GOODRICH CORPORATION
    Inventors: Brandon Hein, James A Mullen, George F. Owens, Nathaniel Ching, Jin Hu
  • Patent number: 8399489
    Abstract: Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
    Type: Grant
    Filed: February 16, 2006
    Date of Patent: March 19, 2013
    Assignee: Astrazeneca AB
    Inventors: Gregory Basarab, Brian Dangel, Paul Robert Fleming, Michael Barry Gravestock, Oluyinka Green, Sheila Irene Hauck, Pamela Hill, Kenneth Gregory Hull, George Mullen, Haihong Ni, Brian Sherer, Fei Zhou
  • Publication number: 20100179150
    Abstract: Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
    Type: Application
    Filed: February 16, 2006
    Publication date: July 15, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Gregory Basarab, Brian Dangel, Paul Robert Fleming, Michael Barry Gravestock, Oluyinka Green, Sheila Irene Hauck, Pamela Hill, Kenneth Gregory Hull, George Mullen, Brian Sherer, Fei Zhou, Haihong Ni
  • Publication number: 20070275954
    Abstract: This invention relates to novel compounds having the Formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of H. pylori infection.
    Type: Application
    Filed: May 19, 2005
    Publication date: November 29, 2007
    Applicant: AstraZeneca AB
    Inventors: Gregory Basarab, Charles Eyermann, Bolin Geng, Madhusudhan Gowravaram, James Loch III, Lawrence MacPherson, Marshall Morningstar, George Mullen, Alex Staz, Andrew Kiely
  • Publication number: 20060223801
    Abstract: Compounds of Formula (1) and their pharmaceutically acceptable salts are described: Formula (1) Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
    Type: Application
    Filed: September 10, 2004
    Publication date: October 5, 2006
    Applicant: AstraZeneca AB
    Inventors: Oluyinka Green, Kenneth Hull, Haihong Ni, Sheila Hauck, George Mullen, Alexander Breeze, Neil Hales, David Timms
  • Publication number: 20050250802
    Abstract: Methods for the treatment of psychotic or intellectual impairment disorders with compounds of formula I, wherein A, R and R1 are as defined in the specification.
    Type: Application
    Filed: July 14, 2005
    Publication date: November 10, 2005
    Inventors: James Loch, George Mullen, Eifion Phillips
  • Patent number: 6683090
    Abstract: Compounds of the general formula I wherein A represents: D represents oxygen, or sulfur and R1, R2 and R3 are as defined in the specification, enantiomers thereof, pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially in the treatment or prophylaxis of psychotic disorders and intellectual impairment disorders.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: January 27, 2004
    Assignee: Astrazeneca AB
    Inventors: Michael Balestra, George Mullen, Eifion Phillips, Richard Schmiesing
  • Patent number: D301975
    Type: Grant
    Filed: October 17, 1986
    Date of Patent: July 4, 1989
    Inventor: George Mullen